Skip to main content

ServiceXS To Use Illumina Platform for European Melanoma Genotyping Study

NEW YORK (GenomeWeb News) – ServiceXS, a genomics and proteomics services firm based in Leiden, the Netherlands, will perform a large-scale genome-wide association study for the European Union’s Melanoma Genetics Consortium, the company said Friday.
 
ServiceXS said it will use Ilumina’s Infinium multiplex technology to genotype 300,000 tag SNPs in 1,800 subjects for the GenoMEL study.
 
Candidate SNPs will be validated in a case-control study including 4,000 melanoma cases and 4,000 control individuals, the company said.
 
Financial terms of the agreement were not released.
 
Further information about the GenoMEL study is available here.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.